Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.20.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets
  As of December 31,  
    2019     2018  
Current:            
Accrued expenses   $ 223,712     $ 168,068  
                 
Stock compensation     838,753       632,254  
                 
Net operating loss carryforward     11,978,595       8,949,957  
                 
Research and development credit carry forward     367,261       488,942  
                 
  Total deferred tax assets     13,408,321       10,239,221  
                 
Valuation allowance     (13,408,321 )     (10,239,221 )
                 
  Deferred tax asset, net of valuation allowance   $ -     $ -  
Schedule of statutory federal income tax rate
    For the Years Ended December 31,  
    2019     2018  
U.S. statutory federal rate     (21.0 )%     (21.0 )%
State income taxes, net of federal tax     (7.0 )%     (7.0 )%
Federal tax rate change     - %     - %
Permanent differences     3.0 %     5.4 %
Prior year true-ups     0.3 %     0.2 %
R&D tax credit     (0.7 )%     (0.5 )%
Change in valuation allowance     25.4 %     22.9 %
Income tax provision (benefit)     - %     - %
Schedule of income tax provision
    For the Years Ended December 31,  
    2019     2018  
Federal            
Current   $ -     $ -  
Deferred     (2,378,218 )     (2,837,776 )
State and local                
Current     -       -  
Deferred     (790,882 )     (943,709 )
Change in valuation allowance     3,169,100       3,781,485  
Income tax provision (benefit)   $ -     $ -